How Nox2-Containing NADPH Oxidase Affects Cortical Circuits in the NMDA Receptor Antagonist Model of Schizophrenia
- 20 April 2013
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 18 (12), 1444-1462
- https://doi.org/10.1089/ars.2012.4907
Abstract
Schizophrenia is a complex neuropsychiatric disorder affecting around 1% of the population worldwide. Its mode of inheritance suggests a multigenic neurodevelopmental disorder with symptoms appearing during late adolescence/early adulthood, with its onset strongly influenced by environmental stimuli. Many neurotransmitter systems, including dopamine, glutamate, and gamma-aminobutyric acid, show alterations in affected individuals, and the behavioral and physiological characteristics of the disease can be mimicked by drugs that produce blockade of N-methyl-d-aspartate glutamate receptors (NMDARs). Mounting evidence suggests that drugs that block NMDARs specifically impair the inhibitory capacity of parvalbumin-expressing (PV+) fast-spiking neurons in adult and developing rodents, and alterations in these inhibitory neurons is one of the most consistent findings in the schizophrenic postmortem brain. Disruption of the inhibitory capacity of PV+ inhibitory neurons will alter the functional balance between excitation and inhibition in prefrontal cortical circuits producing impairment of working memory processes such as those observed in schizophrenia. Mechanistically, the effect of NMDAR antagonists can be attributed to the activation of the Nox2-dependent reduced form of nicotinamide adenine dinucleotide phosphate oxidase pathway in cortical neurons, which is consistent with the emerging role of oxidative stress in the pathogenesis of mental disorders, specifically schizophrenia. Here we review the mechanisms by which NMDAR antagonists produce lasting impairment of the cortical PV+ neuronal system and the roles played by Nox2-dependent oxidative stress mechanisms. The discovery of the pathways by which oxidative stress leads to unbalanced excitation and inhibition in cortical neural circuits opens a new perspective toward understanding the biological underpinnings of schizophrenia.Keywords
This publication has 254 references indexed in Scilit:
- Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of ratsNeuropharmacology, 2012
- Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: What have we learnt?Neuroscience & Biobehavioral Reviews, 2012
- Decreased parvalbumin immunoreactivity in the cortex and striatum of mice lacking the CB1 receptorSynapse, 2011
- Development of NMDA NR2 subunits and their roles in critical period maturation of neocortical GABAergic interneuronsDevelopmental Neurobiology, 2010
- Neural basis of psychosis-related behaviour in the infection model of schizophreniaBehavioural Brain Research, 2009
- Differential role of N-methyl-d-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficitsNeuroscience, 2009
- Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?Neuropharmacology, 2009
- Immunochemical characterization of inhibitory mouse cortical neurons: Three chemically distinct classes of inhibitory cellsJournal of Comparative Neurology, 2009
- Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentialsNeurobiology of Disease, 2009
- NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection techniqueJournal of Neuroscience Methods, 2009